BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//MLSC - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:MLSC
X-ORIGINAL-URL:https://www.masslifesciences.com
X-WR-CALDESC:Events for MLSC
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220119T160000
DTEND;TZID=America/New_York:20220119T160000
DTSTAMP:20260407T065957
CREATED:20220103T201619Z
LAST-MODIFIED:20220103T201619Z
UID:15437-1642608000-1642608000@www.masslifesciences.com
SUMMARY:SeXX and Immunity: Exploring the impact of female biology on immune responses to infectious disease
DESCRIPTION:It’s Time to Address a Knowledge Gap\nThe X chromosome does more than determine sex! When we treat biological sex (XX versus XY chromosomes) as a variable in immunity and diseases\, it can lead to a new understanding of the underpinnings of disease. The COVID-19 pandemic helped amplify awareness about sex-specific differences in immunity against infection\, however\, we still have a lot to learn. Sex differences in disease outcomes are not limited to infectious diseases – they are observed in outcomes of autoimmune diseases and cancers\, and even in response to vaccination. \n\n\n\n\n\n\n\n\n\n\nMIT’s “SeXX and Immunity” Series Addresses Gap\nOn January 19\, 2022\, MIT will kick off a new series of discussions and seminars called “SeXX and Immunity.” These sessions will explore our understanding of sex differences and sex dimorphism in relation to immune responses and how presentations of infectious diseases differ based on biology. \nOur first session will feature Dr. Sabra Klein of Johns Hopkins University\, for a talk titled “SeXX matters for viral infection and vaccination.” \n\n\n\n\n\nSeminar at 4:00PM\, 32-144 \nPoster Session Reception at 5:00PM\, R&D Commons \nRegistration Information\n\n\n\n\n\n\n\n\n\n\nPre-registration deadline: January 18\, 2022 at 12:00PM\nAfter this time\, onsite registration may be available on a space-permitting basis. \nRegistration Fees (in USD) \n— Industry: $25 \n— Academic: $10 \n— Students: Complimentary (must register with academic email address and present a valid student ID.) \n— Poster Submitters: Complimentary with submitted poster (must attend in person. Poster submitters will receive information separately about abstract submission.) \n— Virtual Attendance: Complimentary (poster session not included.) \nNOTE: No refunds can be issued for changes from in-person to virtual attendance. \nPayment methods accepted: Card Card (MasterCard\, Visa\, AMEX\, Discover) or MIT account number. Registration fees are not refundable.
URL:https://www.masslifesciences.com/event/sexx-and-immunity-exploring-the-impact-of-female-biology-on-immune-responses-to-infectious-disease/
LOCATION:Stata Center\, Building 32\, 32 Vassar Street\, Cambridge\, MA\, 02139\, United States
ORGANIZER;CN="MIT":MAILTO:lindsayk@mit.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220118
DTEND;VALUE=DATE:20220128
DTSTAMP:20260407T065957
CREATED:20211004T125406Z
LAST-MODIFIED:20211004T125406Z
UID:14666-1642464000-1643327999@www.masslifesciences.com
SUMMARY:Designing and Implementing AI Solutions for Health Care
DESCRIPTION:Applications of artificial intelligence in health care are expanding rapidly. Despite its great long-term potential\, risks and challenges remain for both AI developers and their partners in health care\, the life sciences industry and digital health. \nThis Harvard Medical School Executive Education program will allow leaders across the ecosystem to gain insights into what it takes to successfully utilize AI in the unique cultural\, economic and regulatory context of health care. Interactive sessions will address technical concepts as well as real-world implementation\, with examples drawn from health care delivery/operations and drug development. \nThe curriculum will feature a combination of live virtual class sessions\, small group application exercises\, pre-work and vigorous discussions. Upon completion of the program\, participants will be able to immediately apply insights gained to the fast-moving and complex health care sector. A certificate of completion will be provided.
URL:https://www.masslifesciences.com/event/designing-and-implementing-ai-solutions-for-health-care-3/
LOCATION:Live Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220111T120000
DTEND;TZID=America/New_York:20220111T130000
DTSTAMP:20260407T065957
CREATED:20211227T135510Z
LAST-MODIFIED:20220107T220155Z
UID:15344-1641902400-1641906000@www.masslifesciences.com
SUMMARY:MLSC 2021 Tax Incentive Program Info Session
DESCRIPTION:MLSC Tax Incentive program supports companies engaged in life sciences research and development\, commercialization and manufacturing in MA. \nThe Massachusetts Life Sciences Center (MLSC) will be launching the next round of the Tax Incentive program supporting companies engaged in life sciences research and development\, commercialization and manufacturing in Massachusetts. The program provides incentives to companies\, of all sizes\, looking to expand their efforts by creating new\, long-term jobs in Massachusetts. \nThe MLSC will be holding an informational session for companies wanting to learn more about the eligibility requirements of the Tax Incentive program. Join us on Jan. 11 at 12 p.m. \nThe MLSC will be accepting applications for the Tax Incentive program from Dec. 6\, 2021 – Feb. 4\, 2022. Learn more about the program. \nA special thank you to our partners at the Massachusetts Biomedical Initiatives for hosting.
URL:https://www.masslifesciences.com/event/mlsc-2021-tax-incentive-program-info-session/
LOCATION:Live Virtual
ORGANIZER;CN="Massachusetts Life Sciences Center":MAILTO:info@masslifesciences.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211217T160000
DTEND;TZID=America/New_York:20211217T180000
DTSTAMP:20260407T065957
CREATED:20211022T182057Z
LAST-MODIFIED:20211022T182057Z
UID:14818-1639756800-1639764000@www.masslifesciences.com
SUMMARY:M2D2 IMPACT Accelerator Pitch-Off
DESCRIPTION:Hear ten medical device startups selected for the IMPACT Accelerator Program pitch their innovation to a panel of investors.\nCalling all Investors\, Medical Device Innovators\, Biotech Entrepreneurs\, and Life Sciences Industry Professionals:\nJoin the worldwide life sciences community as the startups from the Cycle 1 Cohort pitch their medical device solution to a panel of judges. These startups have been working with M2D2\, Asahi Intecc\, and Boston Scientific to advance the commercialization of their innovation through the IMPACT Accelerator Program. \nWhat is IMPACT?\nThe M2D2 IMPACT program is a12-week accelerator program that will run for 6 cycles. The program aims to advance early-stage companies looking to reshape the future of healthcare. Selected companies will have the opportunity to engage with our sponsors’ specialized research calls to help advance their business.
URL:https://www.masslifesciences.com/event/m2d2-impact-accelerator-pitch-off/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211216
DTEND;VALUE=DATE:20211218
DTSTAMP:20260407T065957
CREATED:20211123T215852Z
LAST-MODIFIED:20211123T215852Z
UID:15008-1639612800-1639785599@www.masslifesciences.com
SUMMARY:2021 BioMAN Summit on "Technologies to Expand the Reach of Cell and Gene Therapies"
DESCRIPTION:Join Us!!\nFeaturing Keynote presentations from Professor Bruce Levine of the University of Pennsylvania and Dr. Peter Marks of USFDA. \nThe first FDA-approved cell and gene therapies revolutionized healthcare by bringing novel medicines to patient populations who lacked other treatment options. Progress is needed on multiple fronts to extend the application of these innovative product modalities to new patient populations and disease indications. \nMIT CBI’s BioMAN Consortium will host the 2021 BioMAN Summit\, which brings together thought leaders from industry\, academia\, and government for a series of invited presentations that will:\n– Identify what innovative cell and gene therapies are advancing\nthrough the development pipeline in the immuno-oncology space\nand across other disease indications.\n– Explore what the cell and gene therapy ‘factory of the future’ looks like and how it will meet the technical and logistical challenges of\nscaled-up or scaled-out manufacturing.\n– Discover what novel technologies can address current cell and gene therapy bottlenecks such as supply and variability of raw materials.\n– Examine how analytics can improve process development and manufacturing and decrease the cost of goods for these modalities.\n– Investigate strategies for introducing new technologies in the face of compressed development timelines and accelerated product\napprovals.
URL:https://www.masslifesciences.com/event/2021-bioman-summit-on-technologies-to-expand-the-reach-of-cell-and-gene-therapies/
LOCATION:A Virtual Event\, MA\, United States
ORGANIZER;CN="MIT Center for Biomedical Innovation":MAILTO:mketchum@mit.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211215T120000
DTEND;TZID=America/New_York:20211215T130000
DTSTAMP:20260407T065958
CREATED:20211123T215942Z
LAST-MODIFIED:20211123T215942Z
UID:15012-1639569600-1639573200@www.masslifesciences.com
SUMMARY:Perspectives From the Intersection of Health Care and Technology
DESCRIPTION:Joe Corkery\, MD will discuss his personal journey along the intersection of health care and technology from his perspectives as a physician as well as a technology product leader at Google. In particular\, he will highlight key insights about health care that technology leaders need to understand\, and conversely\, key learnings for health care practitioners about the technology industry.
URL:https://www.masslifesciences.com/event/perspectives-from-the-intersection-of-health-care-and-technology/
LOCATION:Live Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211214T183000
DTEND;TZID=America/New_York:20211214T193000
DTSTAMP:20260407T065958
CREATED:20211123T220212Z
LAST-MODIFIED:20211123T220212Z
UID:14950-1639506600-1639510200@www.masslifesciences.com
SUMMARY:Koch Institute Directors Panel
DESCRIPTION:Celebrate the enduring legacy of cancer research at MIT. Current and former directors reflect on the past five decades of progress—from seminal discoveries in molecular biology and immunology to new innovations in nanotechnology and precision medicine—and look ahead to future advancements in the fight against cancer. Join in the conversation as we commemorate the people\, projects\, and promise of integrative cancer research. \nFeaturing \nPhillip Sharp\, PhD\nDirector: 1985–1991\nInstitute Professor and Professor of Biology \nRichard Hynes\, PhD\nDirector: 1991–2001\nDaniel K. Ludwig Professor for Cancer Research \nTyler Jacks\, PhD\nDirector: 2001–2021\nDavid H. Koch (1962) Professor of Biology and Daniel K. Ludwig Scholar \nMatthew Vander Heiden\, MD\, PhD\nDirector: 2021–present\nLester Wolfe (1919) Professor of Molecular Biology and Professor of Biology \nModerated by Susan Hockfield\, PhD\nMIT President Emerita and Professor of Neuroscience
URL:https://www.masslifesciences.com/event/koch-institute-directors-panel/
LOCATION:Virtual
ORGANIZER;CN="Koch Institute for Integrative Cancer Research at MIT":MAILTO:kievents@mit.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211213
DTEND;VALUE=DATE:20211216
DTSTAMP:20260407T065958
CREATED:20211123T215842Z
LAST-MODIFIED:20211123T215842Z
UID:15011-1639353600-1639612799@www.masslifesciences.com
SUMMARY:MIT-UCL Vaccines Bioprocess Development and Commercialization Workshop
DESCRIPTION:Massachusetts Institute of Technology\, in collaboration with University College London\, is announcing its 2021 Vaccines BioProcess Development & Commercialization Workshop.\nThis three-day workshop will explore the critical issues at the various stages of vaccine development. International experts with over 10 years’ experience in their field will lead delegates in developing their understanding in the research\, development\, operational and regulatory challenges of the vaccine market. In addition to expert lectures and excellent networking opportunities with your peers\, one case study will be conducted during the workshop about manufacturing at-risk with real examples from the influenza manufacturing process. \nThis workshop is suitable for:\n• Scientists and engineers new to the vaccines sector (recent graduates/ research scientists).\n• Scientists and technical managers who wish to broaden their knowledge in various vaccine technologies and platforms\, exploring the interplay between process choices and regulation.\n• Project Managers\, funders and policy-makers wanting to gain an understanding of vaccines. \nConfirmed Speakers Include:\nAlison Armstrong\, Merck Group\nDan Barouch\, Harvard\nBarry Buckland\, UCL\nTania Pereira Chilima\, Univercells\nKimberly Duffy\, Merck\nMark Feinberg\, IAVI\nStefanie Frank\, UCL\nAdrian Hill\, Oxford\nSteve Kolodziej\, Pfizer\nJ. Christopher Love\, MIT\nPeter Marks\, FDA\nMartina Micheletti\, UCL\nDerek O’Hagan\, GSK\nJulia O’Neill\, Moderna\nDon Parsons\, Moderna\nDavid Robinson\, B&MGF\nStacy Springs\, MIT\nDave Sullivan\, Pfizer
URL:https://www.masslifesciences.com/event/mit-ucl-vaccines-bioprocess-development-and-commercialization-workshop/
LOCATION:A Virtual Event\, MA\, United States
ORGANIZER;CN="MIT Center for Biomedical Innovation":MAILTO:mketchum@mit.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211206T090000
DTEND;TZID=America/New_York:20211209T113000
DTSTAMP:20260407T065958
CREATED:20210802T154743Z
LAST-MODIFIED:20210802T154743Z
UID:14362-1638781200-1639049400@www.masslifesciences.com
SUMMARY:Science of Biotech 101 (December 2021)
DESCRIPTION:Member Rate applies for MassBio Member Company\, Other State Bioscience Association Member Company\, MassCONNECT Company\, or Unemployed Individual\nDescription \nScience of Biotech 101 is designed for the non-scientist. The class acts as a survey of the basic biological processes that are foundational to the biopharma and life sciences industry. Participants will apply their new understanding of basic cell and molecular biology to the work of life sciences companies that research and develop therapies and products to improve lives\, enhance agriculture\, and decrease the dependence on fossil fuels. \nSchedule\nMonday\, December 6th\, 2021 9:00-11:30 AM EST\nWednesday\, December 8th\, 2021 9:00-11:30 AM EST\nThursday\, December 9th\, 2021 9:00-11:30 AM EST \nAgenda\nSession 1: Introductions Industry Overview The Raw Materials of Biotechnology: Protein and Cells Industry Applications: The Raw Materials of Biotechnology: DNA \nSession 2: Molecular Biology: From DNA to Protein Genetics: Chromosomes\, Genes and Genomes Industry Applications \nSession 3: Genetic Engineering The Immune System Industry Applications: Mitigating Disease
URL:https://www.masslifesciences.com/event/science-of-biotech-101-december-2021/
LOCATION:Online\, online
ORGANIZER;CN="MassBioEd":MAILTO:communications@massbioed.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211122T080000
DTEND;TZID=America/New_York:20211130T235900
DTSTAMP:20260407T065958
CREATED:20211123T215913Z
LAST-MODIFIED:20211123T215913Z
UID:14990-1637568000-1638316740@www.masslifesciences.com
SUMMARY:Applications open for M2D2 IMPACT Accelerator Cycle 2
DESCRIPTION:IMPACT – Innovative Medical Products – Action\, Commercialization\, Technology \nIMPACT supports bringing your Medical Device or Biotech Innovation to market. Each cycle is aligned with sponsor Areas of Interest and mentor driven to help move forward your milestones. \nApply before midnight on Tuesday 30th November for the chance to work directly with BARDA and M2D2’s exclusive resources for startups. \nhttps://my.reviewr.com/s1/site/M2D2_IMPACT \nFunded by the EDA\, there’s no cost or equity taken! \nCycle 2 commences on January 19th 2022\, check out the website for more information. \nhttps://m2d2impact.com \n#M2D2IMPACT
URL:https://www.masslifesciences.com/event/applications-open-for-m2d2-impact-accelerator-cycle-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211118T120000
DTEND;TZID=America/New_York:20211118T124500
DTSTAMP:20260407T065958
CREATED:20211022T132325Z
LAST-MODIFIED:20211022T132510Z
UID:14801-1637236800-1637239500@www.masslifesciences.com
SUMMARY:Technology as a Change Agent in Health Care
DESCRIPTION:In this Harvard Medical School Executive Education webinar\, Vivian Lee\, PhD\, will discuss lessons from her book\, The Long Fix: Solving America’s Health Care Crisis with Strategies that Work for Everyone\, and from her experiences as a former CEO and dean at University of Utah Health and now President of Verily Health Platforms (Alphabet). She’ll discuss lessons about leading change with respect to three main key constituents in health care—patients\, clinicians and payers (employers)—and explore the role of data and technology in that change.
URL:https://www.masslifesciences.com/event/technology-as-a-change-agent-in-health-care/
LOCATION:Live Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211117T160000
DTEND;TZID=America/New_York:20211117T190000
DTSTAMP:20260407T065958
CREATED:20211104T125156Z
LAST-MODIFIED:20211104T125156Z
UID:14873-1637164800-1637175600@www.masslifesciences.com
SUMMARY:The Business Side of a Biotech Startup
DESCRIPTION:Brent will share insights from his role as the Chief Business Officer and US General Manager of OncoOne\, the world’s experts in developing therapies targeting the macrophage migration inhibitory factor\, or MIF\, for patients with solid tumors and severe inflammatory conditions. \nBrent Meadows has over 25 years of US and Global commercial strategy\, launch marketing\, and business development experience from both large and small biotechnology companies including Johnson & Johnson\, Bristol-Myers Squibb\, Regeneron\, and Biogen. He joined OncoOne this fall as their Chief Business Officer and US General Manager responsible for OncoOne’s partnerships\, collaborations\, and business development efforts. He was the first commercial hire in 2007 for AVEO Oncology where he served as co-program executive for FOTIVDA® (tivozanib) helping to create the scientific narrative and expert engagement which led to the $1.4 billion collaboration with Astellas and the EMEA approval. Mr. Meadows holds an MBA from the Babson F.W. Olin Graduate School of Business and a Bachelors of Business Administration from the University of Richmond. \n_________________________________________________________________________________________ \nOpen networking will follow the presentation for those interested. Participants are welcome to join the event at any point of time. The event is subject to run later than the posted end time as the room will stay open as long as people are actively engaged within the chat room. \n***Event is expected to sell out and NOT ALL RVSPS ARE GUARANTEED ENTRY into the event due to the limited attendee capacity offered on the platform.
URL:https://www.masslifesciences.com/event/the-business-side-of-a-biotech-startup/
ORGANIZER;CN="BioXchange":MAILTO:bioxchange.boston@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211116T180000
DTEND;TZID=America/New_York:20211116T190000
DTSTAMP:20260407T065958
CREATED:20211022T132356Z
LAST-MODIFIED:20211022T132356Z
UID:14764-1637085600-1637089200@www.masslifesciences.com
SUMMARY:Life Science Playground: Best Practices for IP Roadblocks
DESCRIPTION:IP issues are among the most challenging and complex considerations that life science and biotech start-ups may face. Recent years have demonstrated record patent filings\, assertions of intellectual property rights\, and licensing deals created during this exciting and innovative time for the life sciences industry. \nWe aim to explore the costs\, benefit\, and role patents and IP may play in biotech start-up development. And\, in addition\, we will provide guidance on building an IP strategy that supports long-term business objectives and growth. \nCome to our playground with other entrepreneurs and thought leaders in life sciences and hear some best practices around IP roadblocks faced by pharmaceutical and biotech entities.
URL:https://www.masslifesciences.com/event/life-science-playground-best-practices-for-ip-roadblocks/
LOCATION:Online\, online
ORGANIZER;CN="Caldwell Intellectual Property Law":MAILTO:eyob@caldwellip.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211116T160000
DTEND;TZID=America/New_York:20211116T183000
DTSTAMP:20260407T065958
CREATED:20211022T181953Z
LAST-MODIFIED:20211022T181953Z
UID:14816-1637078400-1637087400@www.masslifesciences.com
SUMMARY:Barracuda Bowl Pitch Event
DESCRIPTION:Join us for our annual “Shark Tank”-style pitch event!\nAn impressive lineup of innovative medtech entrepreneurs will face tough questions from a panel of investors regarding their technologies\, current stage of development\, and financial projections.\nThis event is a great opportunity to connect with healthcare entrepreneurs and industry-leading investors from the Boston area.\nVIRTUAL EVENT – Presented via WebEx\nReview the Barracuda Bowl Agenda:\nOpening Remarks/Introductions\nBARDA Ventures presentation\nFireside Chat\nCompany Pitches w/ Q&A\nClosing Remarks\nVirtual Networking
URL:https://www.masslifesciences.com/event/barracuda-bowl-pitch-event-2/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211116T160000
DTEND;TZID=America/New_York:20211116T183000
DTSTAMP:20260407T065958
CREATED:20211004T125628Z
LAST-MODIFIED:20211004T125628Z
UID:14632-1637078400-1637087400@www.masslifesciences.com
SUMMARY:Barracuda Bowl Pitch Event
DESCRIPTION:Join us for our annual “Shark Tank”-style pitch event!\nAn impressive lineup of innovative medtech entrepreneurs will face tough questions from a panel of investors regarding their technologies\, current stage of development\, and financial projections.\nThis event is a great opportunity to connect with healthcare entrepreneurs and industry-leading investors from the Boston area.
URL:https://www.masslifesciences.com/event/barracuda-bowl-pitch-event/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211116
DTEND;VALUE=DATE:20211119
DTSTAMP:20260407T065958
CREATED:20211022T132203Z
LAST-MODIFIED:20211022T132203Z
UID:14783-1637020800-1637279999@www.masslifesciences.com
SUMMARY:Redefining Early Stage Investments (RESI)
DESCRIPTION:The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain\, connecting start-ups with 10 categories of global investors across the silos of drugs\, devices\, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups\, those seeking grants\, seed and angel capital\, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare.
URL:https://www.masslifesciences.com/event/redefining-early-stage-investments-resi/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211109T103000
DTEND;TZID=America/New_York:20211109T113000
DTSTAMP:20260407T065958
CREATED:20211101T185432Z
LAST-MODIFIED:20211101T185648Z
UID:14832-1636453800-1636457400@www.masslifesciences.com
SUMMARY:A Booming Life Science & Biotech Sector: Opportunities & Challenges
DESCRIPTION:The life science industry is a thriving ecosystem propelling the broader Massachusetts — and global — economies forward. Critical infrastructure to support this industry is a paramount concern. This virtual event will explore the unique needs of life science companies in Massachusetts and how the market is evolving. Join conversation leader William Kane from BioMed Realty who will showcase BioMed’s new white paper\, “Anatomy of a Life Sciences Real Estate Platform” and discuss how the tenant/landlord relationships has become even more paramount throughout the pandemic. This event is part of the MassEcon Business Brunch series. Attendees are welcome to participate in the conversation.
URL:https://www.masslifesciences.com/event/a-booming-life-science-biotech-sector-opportunities-challenges/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211105T110000
DTEND;TZID=America/New_York:20211105T130000
DTSTAMP:20260407T065958
CREATED:20211004T125649Z
LAST-MODIFIED:20211004T125803Z
UID:14631-1636110000-1636117200@www.masslifesciences.com
SUMMARY:Student Intern & Employer Mashup
DESCRIPTION:Hear from M2D2 startups and students about gaining real-world experience! \nWho should attend?\n• Current UMass Lowell engineering students and biomedical/nutritional science students\n• Startups and innovators focused on medical devices\, biotech\, digital health technologies\, sensor technologies\, wearable technologies\, robotic technologies \nHear from M2D2 resident startups who will share their experience hiring UMass Lowell students.\nUMass Lowell students will share their experience gaining real-world\, hands-on knowledge working for a startup. \nDetails:\nFace masks required\nLunch & refreshments will be provided\nRegistration is open until Wednesday\, November 3rd
URL:https://www.masslifesciences.com/event/student-intern-employer-mashup/
LOCATION:110 Canal St\, 110 Canal St\, Lowell\, MA\, 01854\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211103T130000
DTEND;TZID=America/New_York:20211103T154500
DTSTAMP:20260407T065958
CREATED:20211022T132343Z
LAST-MODIFIED:20211022T132343Z
UID:14765-1635944400-1635954300@www.masslifesciences.com
SUMMARY:Discover Brigham 2021
DESCRIPTION:Join us virtually as we celebrate and promote the work of the Brigham research\, discovery and innovation community at the 10th annual Discover Brigham. \nGo behind the scenes of discovery to find out how Brigham investigators are pursuing some of the most pressing questions in science in medicine. Discover Brigham gives the public an opportunity to learn about groundbreaking research and meet the expert investigators who make it all possible. And this year\, you can do it all from the comfort and convenience of a computer or smartphone. \nThis year\, Discover Brigham will feature a fireside chat with Lindsey Baden\, MD\, an infectious diseases specialist at the Brigham with expertise in vaccine development for viral diseases who led COVID-19 vaccination research efforts\, and Anne Schuchat\, MD\, Immediate Past Principal Deputy Director of the Center for Disease Control (CDC) who in her 30+ years at CDC was involved in many infectious disease outbreak responses including COVID-19\, H1N1\, Ebola and Zika. Additionally\, selected Brigham Research Institute (BRI) funded researchers will discuss their projects and how BRI funding supported their continued discovery and innovation. The event will also include a virtual poster session with 100 posters to celebrate the work of our junior faculty members\, trainees and staff. \nWe are inviting you to mark your calendars and join us in this celebratory event on November 3rd! \nYou can reach out to discoverbrigham@bwh.harvard.edu if you have any questions.
URL:https://www.masslifesciences.com/event/discover-brigham-2021/
LOCATION:Virtual Event
ORGANIZER;CN="Brigham Research Institute at Brigham and Women's Hospital":MAILTO:bwhbri@partners.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211101T183000
DTEND;TZID=America/New_York:20211101T193000
DTSTAMP:20260407T065958
CREATED:20211022T132249Z
LAST-MODIFIED:20211022T132249Z
UID:14769-1635791400-1635795000@www.masslifesciences.com
SUMMARY:Entrepreneurship and the Koch Institute at MIT
DESCRIPTION:Join Koch Institute investigators on Zoom for a with/in/sight event exploring the relationship between laboratory research and entrepreneurship. From drug discovery to disease detection and cancer immunotherapy\, this evening’s featured startup companies began in MIT’s academic community and are now taking the biotech world by storm. Hear from the founders themselves about why a startup was the right research move to turn innovation into impact.
URL:https://www.masslifesciences.com/event/entrepreneurship-and-the-koch-institute-at-mit/
LOCATION:Koch Institute for Integrative Cancer Research at MIT\, 500 Main Street\, Cambridge\, MA\, 02142\, United States
ORGANIZER;CN="Koch Institute for Integrative Cancer Research at MIT":MAILTO:kievents@mit.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211101
DTEND;VALUE=DATE:20211113
DTSTAMP:20260407T065958
CREATED:20210802T155151Z
LAST-MODIFIED:20210802T155151Z
UID:14363-1635724800-1636761599@www.masslifesciences.com
SUMMARY:Leading Digital Transformation in Health Care
DESCRIPTION:Digital transformation in health care is happening at an increasingly rapid pace. The current global health care crisis is only bolstering the need for technology to provide meaningful solutions. Digital health technologies can make it more convenient for a patient to make an appointment. They can make it easier for doctors to access the right information at the right time. They can make it more efficient for a health system to manage their population and deliver high-value\, high-quality care at a reasonable cost—or to continually improve care through knowledge generation in the model of a learning health system. \nWhile excitement and investment in these technologies is rapidly increasing\, the adoption and value proposition of technology for health care remains complex and multifaceted. Which innovations will provide more cost-effective\, patient-centered\, quality care? How do you differentiate value-producing technologies from hype? As a leader\, what are the critical steps in managing the change process? How do you leverage digital strategies throughout your organization to benefit all aspects of health care? Insights into these questions are critical not just for health systems\, but also business leaders developing industry solutions for health care. \nThis Harvard Medical School Executive Education program provides you with the knowledge\, tools and strategies to design and implement technology-enabled change initiatives in health care. It will feature a combination of live virtual class sessions and self-paced learning and discussions. A certificate of completion will be provided.
URL:https://www.masslifesciences.com/event/leading-digital-transformation-in-health-care-5/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211029T090000
DTEND;TZID=America/New_York:20211029T120000
DTSTAMP:20260407T065958
CREATED:20211022T132147Z
LAST-MODIFIED:20211022T132147Z
UID:14793-1635498000-1635508800@www.masslifesciences.com
SUMMARY:Tufts Initiative on Substance Use & Addiction 2021 Virtual Symposium
DESCRIPTION:Please join us Friday\, October 29 from 9:00AM – 12:00 PM for the Tufts Initiative on Substance Use and Addiction 2021 Virtual Symposium. This is an occasion to showcase the wide variety of research projects funded by the Tufts Initiative on Substance Use and Addiction (TISUA) program aimed at the prevention and treatment of addiction and substance use to help the countless individuals and families who have suffered. \nThe program will include two sessions of panel discussions and lightning talks highlighting outcomes from the first cohort of TISUA awardees. \nTo register for the event\, visit https://tufts.zoom.us/webinar/register/WN_MIBZZijQT3-OsvHZDZbXSA click here. RSVP by October 27th. \nFor additional information or questions\, please visit our website or contact substanceuseinitiative@tufts.edu. \nWe look forward to seeing you there!
URL:https://www.masslifesciences.com/event/tufts-initiative-on-substance-use-addiction-2021-virtual-symposium/
LOCATION:Virtual Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211027T160000
DTEND;TZID=America/New_York:20211027T190000
DTSTAMP:20260407T065958
CREATED:20211022T132337Z
LAST-MODIFIED:20211022T132337Z
UID:14768-1635350400-1635361200@www.masslifesciences.com
SUMMARY:Virtual BioXchange
DESCRIPTION:Miss being able to network with colleagues in the life science industry? We have you covered with the best virtual networking experience through Grapevine Network’s networking platform. Connect with life science colleagues from all over the world. \nBioXchange has gone virtual to allow the best online opportunity to interact with individuals from throughout the life science industry. The event will be hosted on Grapevine Network’s platform which provides an amazing experience that allows attendees the freedom to navigate between different group discussions within an interactive chatroom environment. The platform provides the closest experience to a live networking experience. \nParticipants are welcome to join the event at any point of time. The event is subject to run later than the posted end time as the room will stay open as long as people are actively engaged within the chat room. \n***Event is expected to sell out and NOT ALL RVSPS ARE GUARANTEED ENTRY into the event due to the limited attendee capacity offered on the platform.
URL:https://www.masslifesciences.com/event/virtual-bioxchange-6/
ORGANIZER;CN="BioXchange":MAILTO:bioxchange.boston@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211026T173000
DTEND;TZID=America/New_York:20211026T200000
DTSTAMP:20260407T065958
CREATED:20210819T172014Z
LAST-MODIFIED:20210819T172014Z
UID:14457-1635269400-1635278400@www.masslifesciences.com
SUMMARY:MassBioEd's 20th Anniversary Celebration\, Honoring Champions for Biotechnology Education 2021
DESCRIPTION:The Champions for Biotech Education Awards Reception honors a school\, teacher\, and company for their outstanding advocacy for\, and contributions to\, life sciences education in Massachusetts. In addition\, a student is awarded for their academic excellence and dedication to pursuing biotechnology in college. This year’s celebration will highlight the evolution and impact of MassBioEd’s programs over 20 years\, looking to the next 20 years of continued success in opening career doors to underserved students and building a strong and diverse workforce. Download Admission Information.
URL:https://www.masslifesciences.com/event/massbioeds-20th-anniversary-celebration-honoring-champions-for-biotechnology-education-2021/
LOCATION:Online\, online
ORGANIZER;CN="MassBioEd":MAILTO:communications@massbioed.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211025T120000
DTEND;TZID=America/New_York:20211025T130000
DTSTAMP:20260407T065958
CREATED:20211004T130107Z
LAST-MODIFIED:20211004T130107Z
UID:14615-1635163200-1635166800@www.masslifesciences.com
SUMMARY:Rewriting the Genome for Health: From Bench to Biotech
DESCRIPTION:In this Harvard Medical School Executive Education live virtual webinar\, Sekar Kathiresan\, MD will discuss his journey from being a professor and cardiologist at Harvard Medical School to becoming the co-founder and chief executive officer of Verve Therapeutics. He will discuss leading Verve through its promising preclinical studies\, its recent IPO and the road ahead – and the scientific and leadership lessons learned.
URL:https://www.masslifesciences.com/event/rewriting-the-genome-for-health-from-bench-to-biotech/
LOCATION:Live Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211012T100000
DTEND;TZID=America/New_York:20211013T160000
DTSTAMP:20260407T065958
CREATED:20210908T202238Z
LAST-MODIFIED:20210908T202238Z
UID:14592-1634032800-1634140800@www.masslifesciences.com
SUMMARY:2021 Global Conference on Regulatory Science: Digital Health and Medical Devices
DESCRIPTION:Join us at the “2021 Global Conference on Regulatory Science\,” hosted virtually on October 12-13 by the Harvard-MIT Center for Regulatory Science. This year’s theme of “Digital Health and Medical Devices\,” will address the challenges and opportunities for harnessing digitally enabled technologies in support of optimal patient health outcomes. \nThe conference will include plenary presentations and panel discussions on day one and multi-stakeholder working group sessions on day two. Topics featured at the conference will include:\n• International approaches to device regulation\n• Challenges and opportunities in pediatric device development\n• Pfizer’s implementation of decentralized clinical trials\n• Development of a post-market surveillance network for medical devices\n• Digital innovations in the mental health space \nLearn more and register at https://hmcrs.org/event/global-conference/ \nWe hope to see you there!\nHarvard-MIT CRS
URL:https://www.masslifesciences.com/event/2021-global-conference-on-regulatory-science-digital-health-and-medical-devices/
LOCATION:Virtual Event
ORGANIZER;CN="Harvard-MIT Center for Regulatory Science":MAILTO:hits_regsci@harvard.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211007T090000
DTEND;TZID=America/New_York:20211007T103000
DTSTAMP:20260407T065958
CREATED:20210809T155314Z
LAST-MODIFIED:20210809T155314Z
UID:14428-1633597200-1633602600@www.masslifesciences.com
SUMMARY:Women Who Lead in Life Sciences
DESCRIPTION:A look at the women in the ever-expanding sector of life sciences and biotech. \nHow many women have made it into the C-Suite\, the boardroom\, the labs\, and what does the leadership pipeline look like? \nWe will talk with women in top roles about their personal stories and hear their views on how Life Science and Biotech companies in our region are evolving culture\, policies and programs that will result in more equity and opportunity for women. \nStay Connected and join us for VIRTUAL NETWORKING. Attendees will have the opportunity to connect with others from Boston’s business community! \nSponsored by: Massachusetts Life Sciences Center
URL:https://www.masslifesciences.com/event/women-who-lead-in-life-sciences/
LOCATION:Online\, online
ORGANIZER;CN="Boston Business Journal":MAILTO:boston@bizjournals.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211006T183000
DTEND;TZID=America/New_York:20211006T193000
DTSTAMP:20260407T065958
CREATED:20211004T130304Z
LAST-MODIFIED:20211004T130304Z
UID:14613-1633545000-1633548600@www.masslifesciences.com
SUMMARY:with/in/sight webinar: Oxygenating the Pipeline
DESCRIPTION:This evening webinar profiles the bench to bedside progress of the Cima Lab’s efforts targeting tumor oxygen levels as a vulnerability in cancer. Through innovative prototyping and clinical trials\, researchers have developed a responsive sensor to sample and relay information about oxygen levels that can inform treatment decisions to dramatically affect how tumors respond to radiation therapy. Discover the ins and out of personalized treatment and learn how the team is drawing on resources across the research spectrum to improve cancer treatment and patient outcomes.
URL:https://www.masslifesciences.com/event/with-in-sight-webinar-oxygenating-the-pipeline/
LOCATION:Virtual Event
ORGANIZER;CN="Koch Institute for Integrative Cancer Research at MIT":MAILTO:kievents@mit.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211006T120000
DTEND;TZID=America/New_York:20211006T130000
DTSTAMP:20260407T065958
CREATED:20211004T125822Z
LAST-MODIFIED:20211004T125847Z
UID:14630-1633521600-1633525200@www.masslifesciences.com
SUMMARY:Introduction to Medical Device Human Factors
DESCRIPTION:M2D2’s “Introduction to Medical Device Human Factors” will introduce and define what exactly “human factors” are and how they relate to the making of medical devices.\nSome of the topics that will be covered:\nHuman factors engineering\nHuman factors standards and guidance\nThe HF/UE process\nRisk analysis\nUser interfaces\nMany more topics to be discussed! \nBeth Loring\, MS\, CHFP\nFounder & Principal
URL:https://www.masslifesciences.com/event/introduction-to-medical-device-human-factors/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210930T120000
DTEND;TZID=America/New_York:20210930T130000
DTSTAMP:20260407T065958
CREATED:20210805T225829Z
LAST-MODIFIED:20210805T225829Z
UID:14392-1633003200-1633006800@www.masslifesciences.com
SUMMARY:Grant Writing Workshop:  Non-dilutive grant funding for early-stage technology companies
DESCRIPTION:Attend for an overview of SBIR/STTR programs relating to biomedical and medical device technologies with a focus on NIH and NSF. \nAbout this event: \nAttend to hear Natalie Rudolph go over the following topics: \n• Overview of SBIR/STTR programs relating to biomedical and medical device technologies\,\nwith a focus on NIH and NSF \n• Essential elements of a successful SBIR/STTR project \n• Key components of a competitive SBIR/STTR application \nNatalie will also be hosting 1:1 meetings from 1pm – 3pm for those who are interested in connecting with her further. If you’re interested in scheduling time with her please send us an email at M2D2@uml.edu. \nNatalie S. Rudolph\, Ph.D. \nRudolph Biomedical Consulting \nRudolph Biomedical Consulting works with early-stage technology companies to identify potential non-dilutive funding sources\, design R&D projects\, and write grant applications to fund them. Project areas include biotechnology\, medical devices and telehealth. My focus is Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants and contracts from NIH\, NSF and DOD. However\, my work spans a wide range of opportunities from agencies such as BARDA\, DARPA\, NIH\, NSF\, DoD\, AHRQ and PCORI. My clients include small companies and academic investigators\, and institutions preparing large complex program proposals. \nMy projects begin with a planning exercise to define the goals and deliverables and to outline the proposed work. This allows us to determine the best match with the funding opportunity objectives\, scope\, budget and duration. \nI love working with the energy and enthusiasm of entrepreneurs!
URL:https://www.masslifesciences.com/event/grant-writing-workshop-non-dilutive-grant-funding-for-early-stage-technology-companies/
LOCATION:Virtual Event
END:VEVENT
END:VCALENDAR